Matthew W. Johnson, PhD
- 3Articles
- 20.5KReads1
- 2005–2023Active
- 6Collaborators
- 37Citations2
About
Matthew W. Johnson, PhD, is affiliated with the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. His publications from 2005 to 2023 focus on psychopharmacology, including the study of anxiety, anxiolytics, psychedelics, and the abuse liability of hypnotic drugs. Johnson has contributed to systematic reviews and conceptual frameworks related to clinical trials and drug differentiation. His frequent collaborators include Roland R. Griffiths, Bethea A. Kleykamp, and Eric C. Strain.
Publications
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
May 10, 2023
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.